Overview

Phase I, Multicenter, Open-label, Dose-escalating, Clinical and Pharmacokinetic Study of PM01183 in Patients With Advanced Solid Tumors

Status:
Completed

Trial end date:
2011-06-01

Target enrollment:

Participant gender:

Summary

This is a phase I, multicenter, open-label, dose escalating clinical and pharmacokinetic study of PM01183 for patients with advanced solid tumors

Phase:

Phase 1

Details

Lead Sponsor:

PharmaMar